Literature DB >> 11279636

Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters.

I Oren1, N Haddad, R Finkelstein, J M Rowe.   

Abstract

Between September 1993 and December 1993, during extensive hospital construction and indoor renovation, a nosocomial outbreak of invasive pulmonary aspergillosis occurred in acute leukemia patients treated in a regular ward that has only natural ventilation. The observed infection rate was 50%. Chemoprophylaxis with intravenous continuous low-dose amphotericin B was then instituted as a preventive measure. During the next 18 months invasive pulmonary aspergillosis developed in 43% of acute leukemia patients. After that period a new hematology ward was opened with an air filtration system through high-efficiency particulate air filtration (HEPA) filters, and a bone marrow transplantation program was started on the hematology service. During the following three years, none of the acute leukemia or bone marrow transplantation patients who were hospitalized exclusively in the hematology ward developed invasive pulmonary aspergillosis, although 29% of acute leukemia patients who were housed in a regular ward, because of shortage of space in the new facility, still contracted invasive pulmonary aspergillosis. Overall, 31 patients were diagnosed with invasive pulmonary aspergillosis during almost five years: 74% of patients recovered from invasive pulmonary aspergillosis, and 42% are long-term survivors; 26% of patients died of resistant leukemia with aspergillosis, but no one died of invasive pulmonary aspergillosis alone. In conclusion, during an on-going construction period, an extremely high incidence rate of invasive pulmonary aspergillosis in acute leukemia patients undergoing intensive chemotherapy was observed. Institution of low-dose intravenous amphotericin B prophylaxis marginally reduced the incidence rate of invasive pulmonary aspergillosis. Keeping patients in a special ward with air filtration through a HEPA system eliminated invasive pulmonary aspergillosis completely. Among patients who developed invasive pulmonary aspergillosis, early diagnosis and treatment are probably the explanation for the favorable outcome. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11279636     DOI: 10.1002/ajh.1054

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  29 in total

1.  Pulmonary injury after combined exposures to low-dose low-LET radiation and fungal spores.

Authors:  B Marples; L Downing; K E Sawarynski; J N Finkelstein; J P Williams; A A Martinez; G D Wilson; M D Sims
Journal:  Radiat Res       Date:  2011-01-28       Impact factor: 2.841

Review 2.  Aspergillus infections in transplant recipients.

Authors:  Nina Singh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Fungal microbiota in air-conditioning installed in both adult and neonatal intensive treatment units and their impact in two university hospitals of the central western region, Mato Grosso, Brazil.

Authors:  Sara de Almeida Alves Simões; Diniz Pereira Leite Júnior; Rosane Christine Hahn
Journal:  Mycopathologia       Date:  2011-03-20       Impact factor: 2.574

Review 4.  Hospital epidemiology and infection control in acute-care settings.

Authors:  Emily R M Sydnor; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

5.  Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study).

Authors:  Morena Caira; Anna Candoni; Luisa Verga; Alessandro Busca; Mario Delia; Annamaria Nosari; Cecilia Caramatti; Carlo Castagnola; Chiara Cattaneo; Rosa Fanci; Anna Chierichini; Lorella Melillo; Maria Enza Mitra; Marco Picardi; Leonardo Potenza; Prassede Salutari; Nicola Vianelli; Luca Facchini; Monica Cesarini; Maria Rosaria De Paolis; Roberta Di Blasi; Francesca Farina; Adriano Venditti; Antonella Ferrari; Mariagrazia Garzia; Cristina Gasbarrino; Rosangela Invernizzi; Federica Lessi; Annunziata Manna; Bruno Martino; Gianpaolo Nadali; Massimo Offidani; Laura Paris; Vincenzo Pavone; Giuseppe Rossi; Antonio Spadea; Giorgina Specchia; Enrico Maria Trecarichi; Adriana Vacca; Simone Cesaro; Vincenzo Perriello; Franco Aversa; Mario Tumbarello; Livio Pagano
Journal:  Haematologica       Date:  2015-02       Impact factor: 9.941

6.  Epidemiology and Prevention of Invasive Aspergillosis.

Authors:  David W. Warnock; Rana A. Hajjeh; Brent A. Lasker
Journal:  Curr Infect Dis Rep       Date:  2001-12       Impact factor: 3.725

7.  Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia.

Authors:  Amélie Chabrol; Lise Cuzin; Françoise Huguet; Muriel Alvarez; Xavier Verdeil; Marie Denise Linas; Sophie Cassaing; Jacques Giron; Laurent Tetu; Michel Attal; Christian Récher
Journal:  Haematologica       Date:  2009-12-08       Impact factor: 9.941

8.  Epidemiology of Aspergillus terreus at a university hospital.

Authors:  John W Baddley; Peter G Pappas; Anita C Smith; Stephen A Moser
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

9.  Fungal pollution of indoor environments and its management.

Authors:  A A Haleem Khan; S Mohan Karuppayil
Journal:  Saudi J Biol Sci       Date:  2012-06-15       Impact factor: 4.219

10.  Two years of a fungal aerobiocontamination survey in a Florentine haematology ward.

Authors:  Gabriella Pini; Rosa Donato; Elisabetta Faggi; Rosa Fanci
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.